मर्क एंड कंपनी

मर्क एंड कंपनी(Merck Sharp & Dohme (MSD) outside the United States and Canada) 200px Public (NYSE: MRK) Dow Jones Industrial Average Component Where patients come first 1891 as a subsidiary of Merck KGaA1917 as an independent company Whitehouse Station, New Jersey, United States Richard T. Clark, Chairman of the Board Kenneth Frazier, President and CEO Stanley F. Barshay, EVP and president, Consumer Health Care Adam H. Schechter, president, Global Human Health Richard S. Bowles, Ph.D., chief compliance officer Willie A. Deese, EVP and president, Merck Manufacturing Mirian Graddick-Weir, Ph.D., EVP, Human Resources Peter N. Kellogg, chief financial officer Peter S. Kim, Ph.D., EVP and president, Merck Research Laboratories Raul E. Kohan, president, Animal Health Bruce N. Kuhlik, general counsel J. Chris Scalet, chief information officer, Global Services Mervyn Turner, Ph.D, chief strategy officer 61,500 (2005) Pharmaceuticals GardasilSingulairPropecia/ProscarZocor Vioxx Fosamax See more complete products listing. $58.13B billion USD US$27.4 Billion (FY 2009)Merck (MRK) annual SEC income statement filing via Wikinvest US$4.83 Billion (FY 2009) US$12.9 Billion (FY 2009) US$112 Billion (FY 2009)Merck (MRK) annual SEC balance sheet filing via Wikinvest US$59.1 Billion (FY 2009) merck.com सन्दर्भ